
Jon Matthew Farber
Articles
-
3 weeks ago |
contemporarypediatrics.com | Marian Freedman |Jon Matthew Farber
Published in Journal of Pediatric Gastroenterology and NutritionIn the wake of the no-biopsy approach to diagnosing celiac disease (CD) introduced in the 2012 European Society for Paediatric Gastroenterology and Hepatology and Nutrition guidelines, Israeli investigators demonstrated that a repeated anti–tissue transglutaminase-2 (anti-TG2) test could replace the antiendomysial antibody (EMA) test required by the guidelines as the confirmatory serology test for diagnosing CD.
-
4 weeks ago |
contemporarypediatrics.com | Marian Freedman |Jon Matthew Farber
Published in Acta PaediatricaHow should a positive viral test result influence the management of young infants who have been hospitalized for fever? One proposal comes from a study in a single children’s hospital, where all febrile infants are admitted to a dedicated infectious diseases unit and are tested for respiratory viruses, herpes simplex virus, enterovirus, and parechovirus, then given 24 hours of antibiotic treatment if found to have a viral infection and no growth on bacterial culture.
-
Feb 4, 2025 |
contemporarypediatrics.com | Marian Freedman |Jon Matthew Farber
Analysis of data for infants who underwent esophageal atresia and tracheoesophageal fistula (EA/TEF) repair suggest that the use of intravenous (IV) acetaminophen along with opioids (IV APAP) instead of opioids alone is associated with a longer length of stay (LOS) but decreased daily costs and mortality.
-
Jan 29, 2025 |
contemporarypediatrics.com | Marian Freedman |Jon Matthew Farber
A retrospective review of electronic health records of children with attention-deficit/hyperactivity disorder (ADHD) without autism spectrum disorder (ADHD – ASD) and children with both ADHD and ASD (ADHD + ASD) found that for children with ADHD – ASD, stimulant medications were significantly more effective than α2 agonist (α2A) medications. For those with ADHD + ASD, however, stimulants and α2As had similar effectiveness.
-
Oct 15, 2024 |
contemporarypediatrics.com | Jon Matthew Farber
A retrospective study in 36 children with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or another drug-resistant epilepsy (DRE) found that cannabidiol treatment reduced seizure frequency in two-thirds of patients and was not associated with adverse effects.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →